To cite this paper use one of the standards below:
Glioblastoma Multiforme (GBM) can develop rapidly in the absence of clinical, radiological or morphological diagnosis from a less malignant precursor tumor[1]. Medulloblastoma (MB) is a malignant embryonic tumor of the cerebellum, the incidence of which occurs preferentially in children under 7 years of age[2]. The efficiency of Photodynamic Therapy (PDT) consists of the combination of a photosensitive drug and activation by visible light. The present study is to investigate the gene expression profile of signaling the Epidermal Growth Factor (EGF) pathway in GBM lines MB and after PDT treatment. These findings confirm that the engineering of nanocarriers associated with PDT procedures led to the hypoexpression of the genes that are directly involved in the EGF tumor process. Such findings contribute to the development of advanced protocols that may aid in the in vivo assays available for clinical oncology.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper